Omalizumab in Patients with Severe Asthma and Persistent Sputum Eosinophilia

被引：0
|
作者：
Mukherjee, Manali [1 ,2 ]
Kjarsgaard, Melanie [2 ]
Radford, Katherine [2 ]
Huang, Chynna [2 ]
Leigh, Richard [3 ]
Dorscheid, Del [4 ]
Lemiere, Catherine [5 ]
Boulet, Louis-Philippe [6 ]
Waserman, Susan [1 ]
Martin, James G. [7 ,8 ]
Nair, Parameswaran K. [1 ,2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] Firestone Inst Resp Hlth, Hamilton, ON, Canada
[3] Univ Calgary, Calgary, AB, Canada
[4] Univ British Columbia, Vancouver, BC, Canada
[5] Hop Sacre Coeur, Montreal, PQ, Canada
[6] Laval Univ, Quebec City, PQ, Canada
[7] McGill Univ, Montreal, PQ, Canada
[8] MUHC, Meakins Christie Labs, Res Inst, Montreal, PQ, Canada
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2019年 / 143卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2018.12.984
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
L40
引用
收藏
页码：AB434 / AB434
页数：1
相关论文
共 50 条
  • [1] Omalizumab in patients with severe asthma and persistent sputum eosinophilia
    Mukherjee, Manali
    Kjarsgaard, Melanie
    Radford, Katherine
    Huang, Chynna
    Leigh, Richard
    Dorscheid, Delbert R.
    Lemiere, Catherine
    Boulet, Louis-Philippe
    Waserman, Susan
    Martin, James
    Nair, Parameswaran
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (1):
  • [2] Omalizumab in patients with severe asthma and persistent sputum eosinophilia
    Manali Mukherjee
    Melanie Kjarsgaard
    Katherine Radford
    Chynna Huang
    Richard Leigh
    Delbert R. Dorscheid
    Catherine Lemiere
    Louis-Philippe Boulet
    Susan Waserman
    James Martin
    Parameswaran Nair
    Allergy, Asthma & Clinical Immunology, 15
  • [3] Sputum eosinophilia in severe allergic asthma is not a reliable marker of omalizumab treatment
    Hermanowicz-Salamon, Joanna
    Nejman-Gryz, Patrycja
    Rubinsztajn, Renata
    Paplinska-Goryca, Magdalena
    Chazan, Ryszarda
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [4] Predictors of sputum eosinophilia in severe asthma
    Azim, Adnan
    Barber, Clair
    Lau, Laurie
    Felongco, Mae
    Wheeler, Helen
    Dennison, Paddy
    Kurukulaaratchy, Ramesh
    Howarth, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [5] Evaluating the efficacy of omalizumab in severe persistent asthma patients
    Silveira, Antonio Miguel Ferrao
    Carreto, Luis
    Pardal, Cecilia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [6] Eosinophilia in blood and sputum in patients with severe asthma: a preliminary study
    Ruiz, Victor Guerra
    Segovia, David Soler
    Mesones, Christian Romero
    Arranz, Inigo Ojanguren
    Castellanos, David Espejo
    Sanchez, Olga Luengo
    Blasco, Paula Galvan
    Munoz-Montull, Lidia
    Oyon, Ander Goitisolo
    Gall, Xavier Munoz
    Carmona, Maria Jesus Cruz
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [7] Omalizumab in persistent severe bakers' asthma
    Olivieri, M.
    Biscardo, C. A.
    Turri, S.
    Perbellini, L.
    ALLERGY, 2008, 63 (06) : 790 - 791
  • [8] The Response To Treatment With Omalizumab In Patients With Severe, Persistent Allergic Asthma
    Mogal, R.
    Khachi, H.
    Barnes, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [9] Effective treatment with omalizumab in patient with severe allergic asthma with persistent mild peripheral blood eosinophilia
    Hermanowicz-Salamon, Joanna
    Rubinsztajn, Renata
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2016, 3 : S6 - S9
  • [10] Omalizumab In The Treatment Of Severe Persistent Bakers Asthma
    Ruiz Garcia, M.
    Fernandez Nieto, M.
    Manso Alonso, L.
    Sastre Dominguez, J.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB179 - AB179
12345